Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.
Saved in:
| Title: | Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma. |
|---|---|
| Authors: | Hanssen, Kimberley M.1,2 (AUTHOR), Murray, Jayne1,2 (AUTHOR), Pandher, Ruby1,2 (AUTHOR), Alfred, Stephanie1 (AUTHOR), Gamble, Laura D.1 (AUTHOR), Brand, Jennifer1 (AUTHOR), Mosmann, Erin1 (AUTHOR), Kusuma, Frances K.1 (AUTHOR), Mak, Crystal1 (AUTHOR), Kearns, Adam1 (AUTHOR), Kamili, Alvin1,2 (AUTHOR), Atkinson, Caroline1,2 (AUTHOR), Minchaca, Alexis Z.1,2 (AUTHOR), Bertoldo, Jean1,2 (AUTHOR), Ziegler, David S.1,2,3 (AUTHOR), Mussai, Francis4 (AUTHOR), Cheng, Paul N. M.5 (AUTHOR), Norris, Murray D.1,6 (AUTHOR), Fletcher, Jamie I.1,2 (AUTHOR) jfletcher@ccia.org.au, Haber, Michelle1,2 (AUTHOR) mhaber@ccia.org.au |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 8/14/2025, Vol. 44 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
